痤疮丙酸杆菌
MAPK/ERK通路
TLR2型
生物
促炎细胞因子
信号转导
细胞生长
细胞因子
蛋白激酶A
分泌物
p38丝裂原活化蛋白激酶
细胞培养
分子生物学
激酶
细胞生物学
炎症
免疫学
TLR4型
生物化学
遗传学
细菌
作者
Yu‐Chun Huang,Chao‐Hsun Yang,Tingting Li,Christos C. Zouboulis,Han-Chi Hsu
出处
期刊:Life Sciences
[Elsevier BV]
日期:2015-09-02
卷期号:139: 123-131
被引量:55
标识
DOI:10.1016/j.lfs.2015.07.028
摘要
Propionibacterium acnes has been considered to influence the acne lesions. The present study intended to elucidate the underlying signaling pathways of P. acnes in human sebaceous gland cells relative to the generation of proinflammatory cytokines. Cell-free extracts of P. acnes under stationary growth phase were co-incubated with human immortalized SZ95 sebocytes. Then, cell-free P. acnes extracts-induced cytokine expression was evaluated by measuring mRNA and protein levels using quantitative RT-PCR and ELISA. Changes of phosphorylated cell signaling proteins and transcription factors were measured by Western blots and Milliplex assay. The interactive molecular mechanisms of P. acnes and sebocytes were examined through use of shRNA and the specific inhibitors of signaling pathways. Cell-free extracts of P. acnes significantly stimulated secretion of interleukin (IL)-8 and IL-6 in SZ95 sebocytes. The degradation of IκB-α and increased phosphorylation of IκB-α, p38 mitogen activated protein kinase (MAPK), CREB, and STAT3 were demonstrated. Quantitative RT-PCR measurements revealed that gene expression of IL-8 and Toll-like receptor 2 (TLR2) was enhanced by cell-free extracts of P. acnes. In addition, the NF-κB inhibitor BMS345541, p38 MAPK inhibitor SB203580, or anti-TLR2 neutralizing antibody prevented cell-free P. acnes extracts-induced secretion of IL-8. Knockdown of TLR2 using shRNA exerted similar inhibitory effects on IL-8 expression. Moreover, inhibition of STAT3 activity by STA-21 enhanced P. acnes-mediated secretion of IL-8. Cell-free extracts of P. acnes are capable to activate NF-κB and p38 MAPK pathways and up-regulate secretion of IL-8 through TLR2-dependent signaling in human SZ95 sebocytes.
科研通智能强力驱动
Strongly Powered by AbleSci AI